A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of the study is to evaluate the effect of multiple-doses of itraconazole, phenytoin and paroxetine on the single-dose pharmacokinetics (PK) of poziotinib in healthy adult participants.
Key facts
- Study ID
- NCT04981704
- Run by
- Spectrum Pharmaceuticals, Inc
- People needed
- 74
- Starts
- 2021-04-08
- Expected to finish
- 2021-08-17
- Last updated by the study team
- 2021-09-05
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion, Phoenix clinical facility — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.